Prospective Boots buyer eyes split of group amid sale talks

Boots’ prospective buyer Sycamore Partners is planning to separate the UK retail pharmacy business from its US and healthcare businesses if its bid is successful.
The private equity firm is understood to be looking at a three-way split of Walgreens Boots Alliance with each having distinct capital structures, The Financial Times reported.
The move would result in Walgreens, Boots and speciality pharma unit Shields Health Solutions becoming independent companies. Related StoryBoots rolls out